BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16708050)

  • 21. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.
    Pinkel D; Segraves R; Sudar D; Clark S; Poole I; Kowbel D; Collins C; Kuo WL; Chen C; Zhai Y; Dairkee SH; Ljung BM; Gray JW; Albertson DG
    Nat Genet; 1998 Oct; 20(2):207-11. PubMed ID: 9771718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkin gene alterations in hepatocellular carcinoma.
    Wang F; Denison S; Lai JP; Philips LA; Montoya D; Kock N; Schüle B; Klein C; Shridhar V; Roberts LR; Smith DI
    Genes Chromosomes Cancer; 2004 Jun; 40(2):85-96. PubMed ID: 15101042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization.
    Zimonjic DB; Keck CL; Thorgeirsson SS; Popescu NC
    Hepatology; 1999 Apr; 29(4):1208-14. PubMed ID: 10094966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
    Park SJ; Jeong SY; Kim HJ
    Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of the regions of copy number amplification associated with hepatocellular carcinoma].
    Zhang SG; Gao YT; Song WQ; Du Z; Yang B; Wang YJ; Zhu ZY
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):566-70. PubMed ID: 20021941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
    Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
    FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma.
    Kusano N; Okita K; Shirahashi H; Harada T; Shiraishi K; Oga A; Kawauchi S; Furuya T; Sasaki K
    Cancer; 2002 Feb; 94(3):746-51. PubMed ID: 11857308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of HER-2/Neu status in hepatocellular carcinoma cases.
    Bacaksiz A; Sahin FI; Bilezikci B; Yilmaz Z
    Genet Test; 2008 Jun; 12(2):211-4. PubMed ID: 18452393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
    Takahata T; Ookawa K; Suto K; Tanaka M; Yano H; Nakashima O; Kojiro M; Tamura Y; Tateishi T; Sakata Y; Fukuda S
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):399-407. PubMed ID: 18248513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MDR1/ABCB1 regional amplification in large inverted repeats with asymmetric sequences and microhomologies at the junction sites.
    Kitada K; Yamasaki T
    Cancer Genet Cytogenet; 2007 Oct; 178(2):120-7. PubMed ID: 17954267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance.
    Yao D; Ding S; Burchell B; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):387-95. PubMed ID: 10871337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA.
    Pang Y; Guo W; Wang J; Xu G; Cheng K; Cao G; Wu M; Cheng S; Liu S
    Oncotarget; 2016 Feb; 7(7):8006-18. PubMed ID: 26769853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
    Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
    Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.
    Wong N; Lam WC; Lai PB; Pang E; Lau WY; Johnson PJ
    Am J Pathol; 2001 Aug; 159(2):465-71. PubMed ID: 11485905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
    Kawaguchi K; Honda M; Yamashita T; Shirota Y; Kaneko S
    Biochem Biophys Res Commun; 2005 Apr; 329(1):370-80. PubMed ID: 15721316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
    Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
    Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
    Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
    Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.